Learn how Novartis compressed 39 years of computational chemistry into 9 hours with AWS, screening 10 million compounds and identifying three promising candidates for about $4,000. Novartis Institutes for Biomedical Research’s (NIBR) purpose is to cure, care, and provide medicines that treat and prevent diseases, ease suffering and improve quality of life. With the average time and cost to take a drug to market being 10 years and about $1 billion, NIBR wants to reduce these numbers and they are doing this with high performance computing.
